Ticagrelor effectiveness overestimated by VASP index Platelet inhibition by ticagrelor versus prasugrel in acute coronary syndrome patients according to platelet function tests

International Journal of Cardiology

Volumn 176, Issue 2, 2014, Pages 557-559

  Dillinger, Jean Guillaume ^a   Silberman, Stephane Manzo ^a   Dit Sollier, Claire Bal ^a   Amsallem, Myriam ^a   Sideris, Georgios ^a   Voicu, Sebastian ^a   Henry, Patrick ^a   Drouet, Ludovic ^a  

^a HÔPITAL LARIBOISIÈRE   (France)

Author keywords

Acute coronary syndrome; ADP receptor blockers; Aggregation; Platelets; Prasugrel; Ticagrelor

Indexed keywords

ACETYLSALICYLIC ACID; ADENOSINE DIPHOSPHATE; CLOPIDOGREL; PADGEM PROTEIN; PRASUGREL; TICAGRELOR; VASODILATOR STIMULATED PHOSPHOPROTEIN; ADENOSINE; ANTITHROMBOCYTIC AGENT; PIPERAZINE DERIVATIVE; PURINERGIC P2Y RECEPTOR ANTAGONIST; THIOPHENE DERIVATIVE;

ACUTE CORONARY SYNDROME; ADULT; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; DRUG EFFICACY; DRUG SAFETY; ENZYME METABOLISM; FEMALE; FLOW CYTOMETRY; HUMAN; LETTER; LIGHT TRANSMISSION AGGREGOMETRY; MAJOR CLINICAL STUDY; MALE; PHASE 3 CLINICAL TRIAL; PLATELET REACTIVITY; PROSPECTIVE STUDY; PROTEIN EXPRESSION; THROMBOCYTE AGGREGATION INHIBITION; ANALOGS AND DERIVATIVES; BLOOD; BLOOD CLOTTING PARAMETERS; COMPARATIVE STUDY; MIDDLE AGED; PROCEDURES; TREATMENT OUTCOME;

ACUTE CORONARY SYNDROME; ADENOSINE; HUMANS; MALE; MIDDLE AGED; PIPERAZINES; PLATELET AGGREGATION INHIBITORS; PLATELET FUNCTION TESTS; PROSPECTIVE STUDIES; PURINERGIC P2Y RECEPTOR ANTAGONISTS; THIOPHENES; TREATMENT OUTCOME;

EID: 84922406097     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2014.07.019     Document Type: Article

References (5)

1. Gurbel PA, Bliden KP, Butler K, et al. Randomized double-blind assessment of the ONSET and OFFSET of the antiplatelet effects of ticagrelor versus clopidogrel in patients with stable coronary artery disease: The ONSET/OFFSET study. Circulation 2009; 120: 2577-85.
2. Montalescot G, Sideris G, Cohen R, et al. Prasugrel compared with high-dose clopidogrel in acute coronary syndrome. The randomised, double-blind ACAPULCO study. Thromb Haemost 2010; 103: 213-23.
3. Laine M, Frere C, Toesca R, et al. Ticagrelor versus prasugrel in diabetic patients with an acute coronary syndrome. A pharmacodynamic randomised study. Thromb Haemost 2014; 111: 273-8.
4. Bonello L, Laine M, Kipson N, et al. Ticagrelor increases adenosine plasma concentration in patients with an acute coronary syndrome. J Am Coll Cardiol 2014 Mar 11; 63(9): 872-7.
5. Gessi S, Varani K, Merighi S, Ongini E, Borea PA. A(2A) adenosine receptors in human peripheral blood cells. Br J Pharmacol 2000; 129: 2-11.